Resources

The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.

Showing 1177 Results

NPC Examines CER as Health Reform Takes Hold

What's on the National Pharmaceutical Council's (NPC) radar for 2013? NPC President Dan Leonard takes a closer look at comparative effectiveness research (CER), state health exchanges and benefits,…

US v. Caronia: Related Resources

The 2nd U.S. Circuit Court of Appeals' recent decision on United States vs. Caronia raises a big question for the pharmaceutical industry: will the decision have broader applicability to comparative…

US v. Caronia and CER Communications

A landmark appeals court ruling could open the door for the pharmaceutical industry to discuss information about comparative effectiveness research (CER) results, even when the data examines off…

Understanding Individual Treatment Effects

Next week, health care stakeholders will convene in Washington, DC, to explore the role and challenges of individual treatment effects, or heterogeneity, in developing treatment recommendations,…

Why Individual Patient Differences Matter

At the end of this month, a diverse group of health care stakeholders will convene at a public meeting in Washington, DC, to discuss one of the unintended consequences of comparative effectiveness…